Aurora Cannabis (ACB) vs Tilray Brands (TLRY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Aurora Cannabis (ACB) has outperformed Tilray Brands (TLRY) over the past year, losing 1.2% versus a loss of 79.2%. Over five years, ACB leads with a -93.9% price change compared with -98.2% for TLRY. Tilray Brands is the larger company by market cap ($279.3 million vs $273.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | TLRY |
|---|---|---|
| Share price | $4.16 | $1.89 |
| Market cap | $273.50M | $279.32M |
| 1-day change | -2.35% | -8.70% |
| YTD return | -1.42% | -79.07% |
| 1-year return | -1.19% | -79.23% |
| 5-year return | -93.87% | -98.21% |
| Forward P/E | — | 13.30 |
| EPS (TTM) | $-0.19 | $-1.41 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $915.45M |
| Revenue growth (YoY) | — | +11.46% |
| Net income (latest FY) | — | $-121.40M |
| Gross margin | — | 28.45% |
| Operating margin | — | -6.88% |
| Net margin | — | -13.26% |
| 52-week high | $6.36 | $15.70 |
| 52-week low | $2.56 | $1.87 |
| Distance from 52-week high | -34.59% | -87.96% |
| Analyst consensus | underperform | none |
| Avg. price target upside | — | +202.65% |
| Average volume | 1.31M | 4.35M |
| Shares outstanding | 65.74M | 147.79M |
| Employees | 1,028 | 3,595 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ACB has outperformed TLRY by 78.0 percentage points over the past year.
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Health Care · Medicinal Chemicals and Botanical Products · 1,028 employees
About Tilray Brands
TLRY stock →Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness.
Health Care · Medicinal Chemicals and Botanical Products · 3,595 employees
ACB vs TLRY FAQ
Which is bigger, Aurora Cannabis or Tilray Brands?
Tilray Brands (TLRY) is larger, with a market capitalization of $279.32M compared with $273.50M for Aurora Cannabis (ACB).
Which stock has performed better over the past year, ACB or TLRY?
ACB returned -1.19% over the past 12 months, compared with -79.23% for TLRY (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and Tilray Brands in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.